Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus
Abstract Purpose To study the value of postoperative transcatheter arterial chemoembolization (TACE) to improve the efficacy of hepatectomy and tumor thrombus removal for patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT). Experimental design From January 1996 to Dece...
Gespeichert in:
| Veröffentlicht in: | The American journal of surgery 2009-09, Vol.198 (3), p.313-318 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 318 |
|---|---|
| container_issue | 3 |
| container_start_page | 313 |
| container_title | The American journal of surgery |
| container_volume | 198 |
| creator | Peng, Bao-Gang, M.D He, Qiang, M.D Li, Jia-Ping, M.D Zhou, Fan, M.D |
| description | Abstract Purpose To study the value of postoperative transcatheter arterial chemoembolization (TACE) to improve the efficacy of hepatectomy and tumor thrombus removal for patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT). Experimental design From January 1996 to December 2004, 126 patients with HCC and PVTT were randomly assigned into 2 groups: a control group and a TACE group. The control group underwent liver resection combined with PVTT removal, and the TACE group underwent liver resection combined with adjuvant TACE after surgery. Survival time in the 2 groups was studied. Results The 2 groups were comparable with regard to all clinicopathologic data. The median survival time was 13 months (95% confidence interval [CI] 6.25 to 19.75 months) for the TACE group and 9 months (95% CI 6.90 to 11.10 months) for the control group. Estimated survival rates for 1, 3 and 5 years were better in the TACE group (50.9%, 33.8%, 21.5%; respectively) than the control group (33.3%, 17.0%, 8.5%, respectively; log rank P = .0094). Conclusions Postoperative TACE enhances the effect of liver resection combined with PVTT removal for HCC patients with PVTT. |
| doi_str_mv | 10.1016/j.amjsurg.2008.09.026 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67616232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002961008008957</els_id><sourcerecordid>67616232</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-ac08c6b295d1f6f66ee34dad86021e7f4387ed2067a5b97f7a30d2b33365f9d23</originalsourceid><addsrcrecordid>eNqFks2KFDEQgBtR3HH1EZSA6G3G_Eynk4vLsvgHCx7Uc0gnFSdtpzMm6ZHxWXxY08zgwl6EkFDkq0olX5rmOcEbggl_M2x0GPKcvm8oxmKD5QZT_qBZEdHJNRGCPWxWGGO6lpzgi-ZJzkMNCdmyx80FkVS0VIpV8-faDvNBTwWVpKdsdNlBgYR0qrPXIzI7CBFCH0f_WxcfJ-TDPsUDZATOeaPNEUWHdrDXBUyJ4YhcTKhGHqaS0S9fdqfdaGAc51EnZHQyfopBIz1ZtI-p1IMO4CdU5lCTyy7F0M_5afPI6THDs_N62Xx7_-7rzcf17ecPn26ub9dm2_Gy1gYLw3sqW0scd5wDsK3VVnBMCXRuy0QHlmLe6baXnes0w5b2jDHeOmkpu2xen-rWi_2cIRcVfF661RPEOSveccIpW8CX98Ahzmmqvan6pFvRirbFlWpPlEkx5wRO7ZMPOh0VwWqRpwZ1lqcWeQpLVeXVvBfn6nMfwN5lnW1V4NUZ0NXU6Kox4_M_jhJJCOnayl2dOKiPdvCQVDbVhgHrU3WkbPT_beXtvQpm9FO1Pf6AI-S7W6tMFVZflp-2fDQs6pBtx_4CNxTURA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1924858550</pqid></control><display><type>article</type><title>Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Peng, Bao-Gang, M.D ; He, Qiang, M.D ; Li, Jia-Ping, M.D ; Zhou, Fan, M.D</creator><creatorcontrib>Peng, Bao-Gang, M.D ; He, Qiang, M.D ; Li, Jia-Ping, M.D ; Zhou, Fan, M.D</creatorcontrib><description>Abstract Purpose To study the value of postoperative transcatheter arterial chemoembolization (TACE) to improve the efficacy of hepatectomy and tumor thrombus removal for patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT). Experimental design From January 1996 to December 2004, 126 patients with HCC and PVTT were randomly assigned into 2 groups: a control group and a TACE group. The control group underwent liver resection combined with PVTT removal, and the TACE group underwent liver resection combined with adjuvant TACE after surgery. Survival time in the 2 groups was studied. Results The 2 groups were comparable with regard to all clinicopathologic data. The median survival time was 13 months (95% confidence interval [CI] 6.25 to 19.75 months) for the TACE group and 9 months (95% CI 6.90 to 11.10 months) for the control group. Estimated survival rates for 1, 3 and 5 years were better in the TACE group (50.9%, 33.8%, 21.5%; respectively) than the control group (33.3%, 17.0%, 8.5%, respectively; log rank P = .0094). Conclusions Postoperative TACE enhances the effect of liver resection combined with PVTT removal for HCC patients with PVTT.</description><identifier>ISSN: 0002-9610</identifier><identifier>EISSN: 1879-1883</identifier><identifier>DOI: 10.1016/j.amjsurg.2008.09.026</identifier><identifier>PMID: 19285298</identifier><identifier>CODEN: AJSUAB</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Antineoplastic Combined Chemotherapy Protocols - administration & dosage ; Biological and medical sciences ; Blood clots ; Cancer therapies ; Carcinoma, Hepatocellular - therapy ; Catheters ; Chemoembolization, Therapeutic - methods ; Chemotherapy ; Combined Modality Therapy ; Confidence intervals ; Ethanol ; Experimental design ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Gelatin Sponge, Absorbable ; General aspects ; Hepatectomy ; Hepatocellular carcinoma ; Humans ; Liver ; Liver cancer ; Liver Function Tests ; Liver Neoplasms - therapy ; Liver, biliary tract, pancreas, portal circulation, spleen ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical prognosis ; Medical sciences ; Middle Aged ; Patients ; Portal Vein ; Portal vein tumor thrombus ; Rodents ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the digestive system ; Survival ; Survival analysis ; Survival Rate ; Thrombosis ; Transcatheter arterial chemoembolization ; Treatment Outcome ; Tumors ; Veins & arteries ; Venous Thrombosis - therapy</subject><ispartof>The American journal of surgery, 2009-09, Vol.198 (3), p.313-318</ispartof><rights>Elsevier Inc.</rights><rights>2009 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><rights>Copyright Elsevier Limited Sep 1, 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-ac08c6b295d1f6f66ee34dad86021e7f4387ed2067a5b97f7a30d2b33365f9d23</citedby><cites>FETCH-LOGICAL-c476t-ac08c6b295d1f6f66ee34dad86021e7f4387ed2067a5b97f7a30d2b33365f9d23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002961008008957$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21911175$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19285298$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peng, Bao-Gang, M.D</creatorcontrib><creatorcontrib>He, Qiang, M.D</creatorcontrib><creatorcontrib>Li, Jia-Ping, M.D</creatorcontrib><creatorcontrib>Zhou, Fan, M.D</creatorcontrib><title>Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus</title><title>The American journal of surgery</title><addtitle>Am J Surg</addtitle><description>Abstract Purpose To study the value of postoperative transcatheter arterial chemoembolization (TACE) to improve the efficacy of hepatectomy and tumor thrombus removal for patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT). Experimental design From January 1996 to December 2004, 126 patients with HCC and PVTT were randomly assigned into 2 groups: a control group and a TACE group. The control group underwent liver resection combined with PVTT removal, and the TACE group underwent liver resection combined with adjuvant TACE after surgery. Survival time in the 2 groups was studied. Results The 2 groups were comparable with regard to all clinicopathologic data. The median survival time was 13 months (95% confidence interval [CI] 6.25 to 19.75 months) for the TACE group and 9 months (95% CI 6.90 to 11.10 months) for the control group. Estimated survival rates for 1, 3 and 5 years were better in the TACE group (50.9%, 33.8%, 21.5%; respectively) than the control group (33.3%, 17.0%, 8.5%, respectively; log rank P = .0094). Conclusions Postoperative TACE enhances the effect of liver resection combined with PVTT removal for HCC patients with PVTT.</description><subject>Antineoplastic Combined Chemotherapy Protocols - administration & dosage</subject><subject>Biological and medical sciences</subject><subject>Blood clots</subject><subject>Cancer therapies</subject><subject>Carcinoma, Hepatocellular - therapy</subject><subject>Catheters</subject><subject>Chemoembolization, Therapeutic - methods</subject><subject>Chemotherapy</subject><subject>Combined Modality Therapy</subject><subject>Confidence intervals</subject><subject>Ethanol</subject><subject>Experimental design</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gelatin Sponge, Absorbable</subject><subject>General aspects</subject><subject>Hepatectomy</subject><subject>Hepatocellular carcinoma</subject><subject>Humans</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Liver Function Tests</subject><subject>Liver Neoplasms - therapy</subject><subject>Liver, biliary tract, pancreas, portal circulation, spleen</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Patients</subject><subject>Portal Vein</subject><subject>Portal vein tumor thrombus</subject><subject>Rodents</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the digestive system</subject><subject>Survival</subject><subject>Survival analysis</subject><subject>Survival Rate</subject><subject>Thrombosis</subject><subject>Transcatheter arterial chemoembolization</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><subject>Veins & arteries</subject><subject>Venous Thrombosis - therapy</subject><issn>0002-9610</issn><issn>1879-1883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFks2KFDEQgBtR3HH1EZSA6G3G_Eynk4vLsvgHCx7Uc0gnFSdtpzMm6ZHxWXxY08zgwl6EkFDkq0olX5rmOcEbggl_M2x0GPKcvm8oxmKD5QZT_qBZEdHJNRGCPWxWGGO6lpzgi-ZJzkMNCdmyx80FkVS0VIpV8-faDvNBTwWVpKdsdNlBgYR0qrPXIzI7CBFCH0f_WxcfJ-TDPsUDZATOeaPNEUWHdrDXBUyJ4YhcTKhGHqaS0S9fdqfdaGAc51EnZHQyfopBIz1ZtI-p1IMO4CdU5lCTyy7F0M_5afPI6THDs_N62Xx7_-7rzcf17ecPn26ub9dm2_Gy1gYLw3sqW0scd5wDsK3VVnBMCXRuy0QHlmLe6baXnes0w5b2jDHeOmkpu2xen-rWi_2cIRcVfF661RPEOSveccIpW8CX98Ahzmmqvan6pFvRirbFlWpPlEkx5wRO7ZMPOh0VwWqRpwZ1lqcWeQpLVeXVvBfn6nMfwN5lnW1V4NUZ0NXU6Kox4_M_jhJJCOnayl2dOKiPdvCQVDbVhgHrU3WkbPT_beXtvQpm9FO1Pf6AI-S7W6tMFVZflp-2fDQs6pBtx_4CNxTURA</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>Peng, Bao-Gang, M.D</creator><creator>He, Qiang, M.D</creator><creator>Li, Jia-Ping, M.D</creator><creator>Zhou, Fan, M.D</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20090901</creationdate><title>Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus</title><author>Peng, Bao-Gang, M.D ; He, Qiang, M.D ; Li, Jia-Ping, M.D ; Zhou, Fan, M.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-ac08c6b295d1f6f66ee34dad86021e7f4387ed2067a5b97f7a30d2b33365f9d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antineoplastic Combined Chemotherapy Protocols - administration & dosage</topic><topic>Biological and medical sciences</topic><topic>Blood clots</topic><topic>Cancer therapies</topic><topic>Carcinoma, Hepatocellular - therapy</topic><topic>Catheters</topic><topic>Chemoembolization, Therapeutic - methods</topic><topic>Chemotherapy</topic><topic>Combined Modality Therapy</topic><topic>Confidence intervals</topic><topic>Ethanol</topic><topic>Experimental design</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gelatin Sponge, Absorbable</topic><topic>General aspects</topic><topic>Hepatectomy</topic><topic>Hepatocellular carcinoma</topic><topic>Humans</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Liver Function Tests</topic><topic>Liver Neoplasms - therapy</topic><topic>Liver, biliary tract, pancreas, portal circulation, spleen</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Patients</topic><topic>Portal Vein</topic><topic>Portal vein tumor thrombus</topic><topic>Rodents</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the digestive system</topic><topic>Survival</topic><topic>Survival analysis</topic><topic>Survival Rate</topic><topic>Thrombosis</topic><topic>Transcatheter arterial chemoembolization</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><topic>Veins & arteries</topic><topic>Venous Thrombosis - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peng, Bao-Gang, M.D</creatorcontrib><creatorcontrib>He, Qiang, M.D</creatorcontrib><creatorcontrib>Li, Jia-Ping, M.D</creatorcontrib><creatorcontrib>Zhou, Fan, M.D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peng, Bao-Gang, M.D</au><au>He, Qiang, M.D</au><au>Li, Jia-Ping, M.D</au><au>Zhou, Fan, M.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus</atitle><jtitle>The American journal of surgery</jtitle><addtitle>Am J Surg</addtitle><date>2009-09-01</date><risdate>2009</risdate><volume>198</volume><issue>3</issue><spage>313</spage><epage>318</epage><pages>313-318</pages><issn>0002-9610</issn><eissn>1879-1883</eissn><coden>AJSUAB</coden><abstract>Abstract Purpose To study the value of postoperative transcatheter arterial chemoembolization (TACE) to improve the efficacy of hepatectomy and tumor thrombus removal for patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT). Experimental design From January 1996 to December 2004, 126 patients with HCC and PVTT were randomly assigned into 2 groups: a control group and a TACE group. The control group underwent liver resection combined with PVTT removal, and the TACE group underwent liver resection combined with adjuvant TACE after surgery. Survival time in the 2 groups was studied. Results The 2 groups were comparable with regard to all clinicopathologic data. The median survival time was 13 months (95% confidence interval [CI] 6.25 to 19.75 months) for the TACE group and 9 months (95% CI 6.90 to 11.10 months) for the control group. Estimated survival rates for 1, 3 and 5 years were better in the TACE group (50.9%, 33.8%, 21.5%; respectively) than the control group (33.3%, 17.0%, 8.5%, respectively; log rank P = .0094). Conclusions Postoperative TACE enhances the effect of liver resection combined with PVTT removal for HCC patients with PVTT.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>19285298</pmid><doi>10.1016/j.amjsurg.2008.09.026</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9610 |
| ispartof | The American journal of surgery, 2009-09, Vol.198 (3), p.313-318 |
| issn | 0002-9610 1879-1883 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67616232 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage Biological and medical sciences Blood clots Cancer therapies Carcinoma, Hepatocellular - therapy Catheters Chemoembolization, Therapeutic - methods Chemotherapy Combined Modality Therapy Confidence intervals Ethanol Experimental design Female Gastroenterology. Liver. Pancreas. Abdomen Gelatin Sponge, Absorbable General aspects Hepatectomy Hepatocellular carcinoma Humans Liver Liver cancer Liver Function Tests Liver Neoplasms - therapy Liver, biliary tract, pancreas, portal circulation, spleen Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical prognosis Medical sciences Middle Aged Patients Portal Vein Portal vein tumor thrombus Rodents Surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the digestive system Survival Survival analysis Survival Rate Thrombosis Transcatheter arterial chemoembolization Treatment Outcome Tumors Veins & arteries Venous Thrombosis - therapy |
| title | Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T10%3A59%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adjuvant%20transcatheter%20arterial%20chemoembolization%20improves%20efficacy%20of%20hepatectomy%20for%20patients%20with%20hepatocellular%20carcinoma%20and%20portal%20vein%20tumor%20thrombus&rft.jtitle=The%20American%20journal%20of%20surgery&rft.au=Peng,%20Bao-Gang,%20M.D&rft.date=2009-09-01&rft.volume=198&rft.issue=3&rft.spage=313&rft.epage=318&rft.pages=313-318&rft.issn=0002-9610&rft.eissn=1879-1883&rft.coden=AJSUAB&rft_id=info:doi/10.1016/j.amjsurg.2008.09.026&rft_dat=%3Cproquest_cross%3E67616232%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1924858550&rft_id=info:pmid/19285298&rft_els_id=S0002961008008957&rfr_iscdi=true |